143.50
-2.25
(-1.54%)
At close: 3:30:25 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 17 | 18 |
| Avg. Estimate | 975.5M | 1.05B | 4.09B | 4.37B |
| Low Estimate | 967.11M | 1.03B | 4.02B | 4.14B |
| High Estimate | 985M | 1.08B | 4.16B | 4.84B |
| Year Ago Sales | 997.43M | 1.03B | 4B | 4.09B |
| Sales Growth (year/est) | -2.20% | 2.55% | 2.33% | 6.72% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALGN.VI | -- | -- | -- | -- |
| S&P 500 | 6.79% | 5.59% | 9.06% | 14.11% |
Upgrades & Downgrades
| Maintains | Mizuho: Outperform to Outperform | 3/25/2025 |
| Reiterates | Piper Sandler: Overweight to Overweight | 3/18/2025 |
| Initiated | Wells Fargo: Overweight | 2/14/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 2/6/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 2/6/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/6/2025 |